Volume 14 Supplement 2
An extensive update to the prominent and widely-popular Practical Guide for Allergy and Immunology in Canada published in 2011, this broad-ranging supplement is designed to provide all healthcare professionals with a comprehensive, yet easy-to-follow, series of peer-reviewed articles focussed on all of the common conditions dealt with in the field of allergy and immunology.
Edited by Harold Kim, Richard Warrington and Wade Watson
Publication of this supplement has been supported by AstraZeneca, Boehringer Ingelheim, CSL Behring Canada Inc., MEDA Pharmaceuticals Ltd., Merck Canada Inc., Pfizer Canada Inc., Shire Pharma Canada ULC, Stallergenes Greer Canada, Takeda Canada, Teva Canada Innovation, Aralez Tribute and Pediapharm. The articles have undergone the journal's standard peer review process for supplements. All Supplement Editors confirm they were not involved in the review process of papers that they are listed as authors.
Please note a major correction to the article 'Eosinophilic esophagitis' has been published. Follow the
correction link for the latest version.
Beyond structural and chemical barriers to pathogens, the immune system has two fundamental lines of defense: innate immunity and adaptive immunity. Innate immunity is the first immunological mechanism for fig...
Asthma is the most common respiratory disorder in Canada. Despite significant improvement in the diagnosis and management of this disorder, the majority of Canadians with asthma remain poorly controlled. In mo...
Allergic rhinitis is a common disorder that is strongly linked to asthma and conjunctivitis. It is usually a long-standing condition that often goes undetected in the primary-care setting. The classic symptoms...
Atopic dermatitis (AD) is a common, chronic skin disorder that can significantly impact the quality of life of affected individuals as well as their families. Although the pathogenesis of the disorder is not c...
Allergen-specific immunotherapy is a potentially disease-modifying therapy that is effective for the treatment of allergic rhinitis/conjunctivitis, allergic asthma and stinging insect hypersensitivity. However...
Anaphylaxis is an acute, potentially fatal systemic allergic reaction with varied mechanisms and clinical presentations. Although prompt recognition and treatment of anaphylaxis are imperative, both patients a...
Food allergy is defined as an adverse immunologic response to a food protein. Food-related reactions are associated with a broad range of signs and symptoms that may involve any body system, including the skin...
Non-immunoglobulin E (IgE)-mediated food hypersensitivity includes a spectrum of disorders that predominantly affect the gastrointestinal tract. This review will focus on the following more common non-IgE-medi...
Food allergy is a growing public health problem, and in many affected individuals, the food allergy begins early in life and persists as a lifelong condition (e.g., peanut allergy). Although early clinical pra...
Eosinophilic esophagitis (EoE) is an atopic condition of the esophagus that has become increasingly recognized over the last 15 years. Diagnosis of the disorder is dependent on the patient’s clinical manifesta...
The Correction to this article has been published in Allergy, Asthma & Clinical Immunology 2019 15:22
Urticaria (hives) is a common disorder that often presents with angioedema (swelling that occurs beneath the skin). It is generally classified as acute or chronic. Second-generation, non-sedating, non-impairin...
Drug allergy encompasses a spectrum of immunologically-mediated hypersensitivity reactions with varying mechanisms and clinical presentations. This type of adverse drug reaction not only affects patient qualit...
Primary immunodeficiency disorder (PID) refers to a large heterogeneous group of disorders that result from defects in immune system development and/or function. PIDs are broadly classified as disorders of ada...
The official journal of CSACI
Citation Impact 2023
Journal Impact Factor: 2.6
5-year Journal Impact Factor: 3.5
Source Normalized Impact per Paper (SNIP): 0.904
SCImago Journal Rank (SJR): 0.749
Speed 2023
Submission to first editorial decision (median days): 18
Submission to acceptance (median days): 140
Usage 2023
Downloads: 1,545,686
Altmetric mentions: 2,123